Showing results (61-70 of 116) with videos related to
Sort By:
Pageof 12
Cancer Medicine|January 10, 2014
Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patientsKazuya Nagano, So-Ichiro Kanasaki, Takuya Yamashita, et al.Biomaterials|September 25, 2010
Acute phase proteins as biomarkers for predicting the exposure and toxicity of nanomaterialsKazuma Higashisaka, Yasuo Yoshioka, Kohei Yamashita, et al.Biomaterials|October 12, 2010
Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteinsSunao Imai, Kazuya Nagano, Yasunobu Yoshida, et al.The Journal of Biological Chemistry|May 14, 2020
Structural optimization of a TNFR1-selective antagonistic TNFα mutant to create new-modality TNF-regulating biologicsMasaki Inoue, Yuta Tsuji, Chinatsu Yoshimine, et al.Biomaterials|September 22, 2009
The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNFHiroko Shibata, Yasuo Yoshioka, Yasuhiro Abe, et al.Biochemical and Biophysical Research Communications|October 10, 2007
Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptideToshiki Sugita, Tomoaki Yoshikawa, Yohei Mukai, et al.Cytokine|September 26, 2008
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis modelsHiroko Shibata, Yasuo Yoshioka, Akiko Ohkawa, et al.Nanotechnology|September 14, 2013
Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damageTakashi Nagano, Kazuma Higashisaka, Akiyoshi Kunieda, et al.Journal of Biochemistry|April 24, 2009
Fast binding kinetics and conserved 3D structure underlie the antagonistic activity of mutant TNF: useful information for designing artificial proteo-antagonistsYohei Mukai, Teruya Nakamura, Yasuo Yoshioka, et al.The Journal of Biological Chemistry|February 26, 2017
A trimeric structural fusion of an antagonistic tumor necrosis factor-α mutant enhances molecular stability and enables facile modificationMasaki Inoue, Daisuke Ando, Haruhiko Kamada, et al.Pageof 12